Future of the Research-Grade Proteins Market: Strategic Analysis and Forecast to 2034

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Research-Grade Proteins Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
Recent years have seen a significant expansion in the market size for research-grade proteins. The market, which was valued at $1.11 billion in 2024, is projected to rise to $1.33 billion in 2025, marking a compound annual growth rate (CAGR) of 20.4%. A multitude of factors can be credited for this historic period of growth including heightened research endeavors, a surge in R&D initiatives within the pharmaceutical and biotechnology sectors, increasing demand for tailored medicine, escalating government and academic institute investments, and strategic procurement and partnerships.

Research-Grade Proteins Market Size Forecast: What's the Projected Valuation by 2029?
In the coming years, a swift expansion is predicted in the market size of research-grade proteins, reaching " $2.74 billion in 2029 with a compound annual growth rate (CAGR) of 19.7%. Factors contributing to this projected growth during the forecast period are the progression in proteomics research, an increase in clinical trials, combination of AI and data analytics, usage of research-grade proteins in industry applications, as well as a rising need for sophisticated research tools. Key trends identified during the predicted period include raising awareness towards novel technologies, technological progress in the biotech industry, improvements in proteomics and genomics, an extended application for drug creation, and advanced research implements in the arenas of biotechnology and pharmaceuticals.

View the full report here:
https://www.thebusinessresearchcompany.com/report/research-grade-proteins-global-market-report

What Are the Drivers Transforming the Research-Grade Proteins Market?
The research-grade proteins market is expected to be propelled by the increasing number of clinical trials. These trials are research studies that examine the safety and efficacy of new medical treatments, interventions, or devices on humans. The surge in clinical trials can be attributed to advancements in medical research, disease burden, regulatory changes, patient demand, and industry investment. Research-grade proteins play a crucial role in these trials as they are used in biomarker development, assay development, drug target identification, quality control, and as reference standards, which ensure the correctness and trustworthiness of experimental data. For example, according to ClinicalTrials.gov, a US-based clinical trial registry, there were 477,234 clinical trials registered worldwide on ClinicalTrials.gov by the end of 2023 which is an increase, compared to 437,512 registered clinical trials in 2022. Thus, the upswing in the number of clinical trials is steering the growth of the research-grade proteins market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15917&type=smp

What Trends Will Shape the Research-Grade Proteins Market Through 2029 and Beyond?
In the field of research-grade proteins, leading businesses are advancing their efforts in cultivating Cas9 proteins to fortify their role and usage in genome manipulation and other biotech endeavors. Cas9 proteins assist in genome editing, serving as molecular tools that slice DNA at certain points as directed by a guide RNA (gRNA). One example occurred in April 2022 when Thermo Fisher Scientific Inc., a biotech company based in the USA, launched their groundbreaking GMP-manufactured Gibco CTS TrueCut Cas9 Protein. This Cas9 protein was produced under the stringent conditions of the Good Manufacturing Practice (GMP), signifying its superior quality and clinical compliance. It is specifically designed to facilitate genome editing projects with high accuracy and efficacy, paving the way for significant progress in genetic engineering and therapeutic innovation.

Which Segments in the Research-Grade Proteins Market Offer the Most Profit Potential?
The research-grade proteins market covered in this report is segmented -

1) By Product: Cytokines And Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones, Other Products
2) By Host Cell: Mammalian Cells, Bacterial Cells, Fungi And Yeast, Insect Cells, Other Host Cells
3) By End-Use: Pharmaceutical And Biotechnology Companies, Academic And Research Institute, Other End-Uses

Subsegments:
1) By Cytokines And Growth Factors: Interleukins, Interferons, Colony Stimulating Factors, Erythropoietin, Granulocyte Macrophage Colony-Stimulating Factor
2) By Antibodies: Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies, Conjugated Antibodies
3) By Immune Checkpoint Proteins: PD-1 Inhibitors, PD-L1 Inhibitors, CTLA-4 Inhibitors
4) By Virus Antigens: HIV Antigens, Hepatitis Antigens, Influenza Antigens, Hepatitis B Antigens
5) By Enzymes: Restriction Enzymes, Proteases, Ligases, Kinases
6) By Recombinant Regulatory Proteins: Transcription Factors, Regulatory Enzymes, Epigenetic Modifiers
7) By Hormones: Insulin, Thyroid Hormones, Growth Hormones, Adrenaline
8) By Other Products: Peptides, Serum Proteins, Antigen-Binding Proteins

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15917&type=smp

Which Firms Dominate the Research-Grade Proteins Market by Market Share and Revenue in 2025?
Major companies operating in the research-grade proteins market are Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Bio-Techne, Stemcell Technologies Inc., Miltenyi Biotec, GenScript Biotech Corporation, Sino Biological Inc., ACROBiosystems, OriGene Technologies Inc., RayBiotech Inc., Rockland Immunochemicals Inc., Proteintech Group Inc., Novus Biologicals LLC, Active Motif, Aviva Systems Biology Corporation, StressMarq Biosciences Inc., Abnova Corporation, AnaSpec, Biomatik, Prospec-Tany Technogene Ltd., Cusabio Technology LLC, United States Biological, Laurus Bio, Boster Biological Technology, AMS Biotechnology Europe Ltd (AMSBIO)

Which Regions Offer the Highest Growth Potential in the Research-Grade Proteins Market?
North America was the largest region in the research-grade proteins market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the research-grade proteins market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15917

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.